Stockreport

Arcellx Provides Third Quarter 2025 Financial Results

Arcellx, Inc.  (ACLX) 
PDF   REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunoth [Read more]